Publication:
A Plain Language Summary on the Effectiveness of Cladribine Tablets Compared With Other Oral Treatments for Multiple Sclerosis: Results From the MSBase Registry

dc.authorwosidLaureys, Guy/Aah-6369-2019
dc.authorwosidKuhle, Jens/Age-3474-2022
dc.authorwosidSoysal, Aysun/Aax-7696-2021
dc.authorwosidHorakova, Dana/D-4649-2011
dc.authorwosidTerzi̇, Murat/Aaa-1284-2021
dc.authorwosidVan Pesch, Vincent/Aak-9506-2020
dc.contributor.authorSpelman, Tim
dc.contributor.authorOzakbas, Serkan
dc.contributor.authorAlroughani, Raed
dc.contributor.authorTerzi, Murat
dc.contributor.authorHodgkinson, Suzanne
dc.contributor.authorLaureys, Guy
dc.contributor.authorMSBase Study Grp
dc.contributor.authorIDKuhle, Jens/0000-0002-6963-8892
dc.contributor.authorIDSánchez Menoyo, José Luis/0000-0003-2634-8294
dc.contributor.authorIDAl Asmi, Abdullah/0000-0002-2851-8157
dc.contributor.authorIDVan Pesch, Vincent/0000-0003-2885-9004
dc.date.accessioned2025-12-11T01:33:54Z
dc.date.issued2023
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Spelman, Tim; Butzkueven, Helmut] MSBase Fdn, Melbourne, Australia; [Ozakbas, Serkan] Dokuz Eylul Univ, Izmir, Turkiye; [Alroughani, Raed] Amiri Hosp, Sharq, Kuwait; [Terzi, Murat] 19 Mayis Univ, Dept Neurol, Samsun, Turkiye; [Hodgkinson, Suzanne] Liverpool Hosp, Sydney, Australia; [Laureys, Guy] Univ Hosp Ghent, Ghent, Belgium; [Kalincik, Tomas] Royal Melbourne Hosp, MS Ctr, Dept Neurol, Melbourne, Australia; [Kalincik, Tomas] Univ Melbourne, Dept Med, CORe, Melbourne, Australia; [Butzkueven, Helmut] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Australia; [Yamout, Bassem] Harley St Med Ctr, Neurol Inst, Abu Dhabi, U Arab Emirates; [Yamout, Bassem] Amer Univ Beirut, Med Ctr, Beirut, Lebanon; [Lechner-Scott, Jeannette] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, Australia; [Lechner-Scott, Jeannette] Hunter New England Hlth, Dept Neurol, John Hunter Hosp, Newcastle, Australia; [Soysal, Aysun] Bakirkoy Educ & Res Hosp Psychiat & Neurol Dis, Istanbul, Turkiye; [Kuhle, Jens] Univ Hosp Basel, Multiple Sclerosis Ctr, Dept Head Spine & Neurosurg, Neurol, Basel, Switzerland; [Kuhle, Jens] Univ Hosp Basel, Multiple Sclerosis Ctr, Dept Biomed, Neurol, Basel, Switzerland; [Kuhle, Jens] Univ Hosp Basel, Multiple Sclerosis Ctr, Dept Clin Res, Neurol, Basel, Switzerland; [Kuhle, Jens] Univ Hosp Basel, Res Ctr Clin Neuroimmunol & Neurosci RC2NB, Basel, Switzerland; [Kuhle, Jens] Univ Basel, Basel, Switzerland; [Sanchez-Menoyo, Jose Luis] Galdakao Usansolo Univ Hosp, Biocruces Bizkaia Hlth Res Inst, Dept Neurol, Osakidetza Basque Hlth Serv, Galdakao, Spain; [Morgado, Yolanda Blanco] Hosp Clin Barcelona, Ctr Neuroimmunol, Serv Neurol, Barcelona, Spain; [Spitaleri, Daniele L. A.] Azienda Osped Rilievo Nazl San Giuseppe Moscati Av, Avellino, Italy; [van Pesch, Vincent] UCLouvain, Clin Univ St Luc, Brussels, Belgium; [Horakova, Dana] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Horakova, Dana] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Horakova, Dana] Gen Univ Hosp, Prague, Czech Republic; [Ampapa, Radek] Nemocnice Jihlava, Jihlava, Czech Republic; [Patti, Francesco] GF Ingrassia, Dept Med & Surg Sci & Adv Technol, Catania, Italy; [Macdonell, Richard] Austin Hlth, Dept Neurol, Melbourne, Australia; [Al-Asmi, Abdullah] SQU, Coll Med & Hlth Sci, Dept Med, Neurol Unit, Al Khoud, Oman; [Al-Asmi, Abdullah] SQU, Sultan Qaboos Univ Hosp, Al Khoud, Oman; [Gerlach, Oliver] Zuyderland Med Ctr, Acad MS Ctr Zuyderland, Dept Neurol, Sittard Geleen, Netherlands; [Gerlach, Oliver] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Oh, Jiwon] Univ Toronto, St Michaels Hosp, Div Neurol, Toronto, ON, Canada; [Altintas, Ayse] Koc Univ, Sch Med, Istanbul, Turkiye; [Altintas, Ayse] Koc Univ, Res Ctr Translat Med KUTTAM, Istanbul, Turkiye; [Tundia, Namita; Wong, Schiffon L.] EMD Serono Res & Dev Inst Inc, Billerica, MA USAen_US
dc.descriptionKuhle, Jens/0000-0002-6963-8892; Sánchez Menoyo, José Luis/0000-0003-2634-8294; Al Asmi, Abdullah/0000-0002-2851-8157; Van Pesch, Vincent/0000-0003-2885-9004;en_US
dc.description.abstractWhat is this summary about?Patient registries contain anonymous data from people who share the same medical condition. The MSBase registry contains information from over 80,000 people living with multiple sclerosis (MS) across 41 countries.Using information from the MSBase registry, the GLIMPSE (Generating Learnings In MultiPle SclErosis) study looked at real-life outcomes in 3475 people living with MS who were treated with cladribine tablets (Mavenclad((R))) compared with other oral treatments.What were the results?Results showed that people treated with cladribine tablets stayed on treatment for longer than other treatments given by mouth. They also had fewer relapses (also called flare ups of symptoms) than people who received a different oral treatment for their MS.What do the results mean?The results provide evidence that, compared with other oral treatments for MS, cladribine tablets are an effective medicine for people living with MS.en_US
dc.description.woscitationindexEmerging Sources Citation Index
dc.identifier.doi10.2217/nmt-2023-0005
dc.identifier.endpage221en_US
dc.identifier.issn1758-2024
dc.identifier.issn1758-2032
dc.identifier.issue4en_US
dc.identifier.pmid37287269
dc.identifier.scopusqualityQ2
dc.identifier.startpage215en_US
dc.identifier.urihttps://doi.org/10.2217/nmt-2023-0005
dc.identifier.urihttps://hdl.handle.net/20.500.12712/44642
dc.identifier.volume13en_US
dc.identifier.wosWOS:001025040700002
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofNeurodegenerative Disease Managementen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCladribine Tabletsen_US
dc.subjectDimethyl Fumarate (Tecfidera(& Regen_US
dc.subject))en_US
dc.subjectFingolimod (Gilenya(& Regen_US
dc.subject))en_US
dc.subjectLay Summaryen_US
dc.subjectMultiple Sclerosisen_US
dc.subjectRelapsesen_US
dc.subjectTeriflunomide (Aubagio(& Regen_US
dc.subject))en_US
dc.subjectTreatment Optionsen_US
dc.titleA Plain Language Summary on the Effectiveness of Cladribine Tablets Compared With Other Oral Treatments for Multiple Sclerosis: Results From the MSBase Registryen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files